STAAR Surgical Retained Earnings (Accumulated Deficit) 2010-2024 | STAA

STAAR Surgical retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
STAAR Surgical Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-47
2022 $-69
2021 $-111
2020 $-136
2019 $-142
2018 $-156
2017 $-161
2016 $-159
2015 $-147
2014 $-140
2013 $-132
2012 $-132
2011 $-131
2010 $-132
2009 $-132
STAAR Surgical Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-33
2024-06-30 $-43
2024-03-31 $-51
2023-12-31 $-47
2023-09-30 $-55
2023-06-30 $-64
2023-03-31 $-70
2022-12-31 $-69
2022-09-30 $-78
2022-06-30 $-89
2022-03-31 $-102
2021-12-31 $-111
2021-09-30 $-116
2021-06-30 $-122
2021-03-31 $-131
2020-12-31 $-136
2020-09-30 $-139
2020-06-30 $-143
2020-03-31 $-142
2019-12-31 $-142
2019-09-30 $-148
2019-06-30 $-151
2019-03-31 $-154
2018-12-31 $-156
2018-09-30 $-157
2018-06-30 $-159
2018-03-31 $-161
2017-12-31 $-161
2017-09-30 $-161
2017-06-30 $-162
2017-03-31 $-161
2016-12-31 $-159
2016-09-30 $-159
2016-06-30 $-157
2016-03-31 $-155
2015-12-31 $-147
2015-09-30 $-146
2015-06-30 $-144
2015-03-31 $-143
2014-12-31 $-140
2014-09-30 $-138
2014-06-30 $-135
2014-03-31 $-133
2013-12-31 $-132
2013-09-30 $-131
2013-06-30 $-132
2013-03-31 $-132
2012-12-31 $-132
2012-09-30 $-131
2012-06-30 $-131
2012-03-31 $-130
2011-12-31 $-131
2011-09-30 $-131
2011-06-30 $-131
2011-03-31 $-132
2010-12-31 $-132
2010-09-30 $-131
2010-06-30 $-130
2010-03-31 $-129
2009-12-31 $-132
2009-09-30 $-131
2009-06-30 $-129
2009-03-31 $-128
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.312B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49